Carasent ASA Cash Flow Conversion Efficiency
Carasent ASA cash flow conversion efficiency. Based on the latest financial reports, Carasent ASA (CARA) has a cash flow conversion efficiency ratio of 0.032x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr25.37 Million ≈ $2.73 Million USD) by net assets (Skr792.47 Million ≈ $85.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Carasent ASA (2002–2025)
Cash flow conversion efficiency of Carasent ASA from 2002 to 2025. This chart illustrates how Carasent ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CARA stock price and chart for real-time trading data and today's change.
Carasent ASA Cash Flow Conversion Ratio Explained
Carasent ASA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Carasent ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carasent ASA ranked by their cash flow conversion efficiency. Also see market cap of Carasent ASA for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beacon Minerals Limited
AU:BCN
|
0.362x |
|
Zhejiang Haiyan Power System Resources Environmental Technology Co. Ltd. A
SHG:688565
|
0.011x |
|
Mobiltel Iletisim Hizmetleri Sanayi ve Ticaret AS
IS:MOBTL
|
-0.014x |
|
Landmark Bancorp Inc
NASDAQ:LARK
|
0.020x |
|
Acrow Ltd
AU:ACF
|
0.085x |
|
MPC Münchmeyer Petersen Capital AG
F:MPCK
|
0.058x |
|
Haad Thip Public Company Limited
BK:HTC
|
0.108x |
|
Crexendo Inc
NASDAQ:CXDO
|
0.035x |
Annual Cash Flow Conversion Efficiency for Carasent ASA (2002–2025)
The table below shows the annual cash flow conversion efficiency of Carasent ASA from 2002 to 2025. Review Carasent ASA free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr808.00 Million ≈ $86.95 Million |
Skr40.44 Million ≈ $4.35 Million |
0.050x | +18.44% |
| 2024-12-31 | Skr865.73 Million ≈ $93.17 Million |
Skr36.58 Million ≈ $3.94 Million |
0.042x | +1003.68% |
| 2023-12-31 | Skr955.41 Million ≈ $102.82 Million |
Skr-4.47 Million ≈ $-480.72K |
-0.005x | -117.06% |
| 2022-12-31 | Skr1.23 Billion ≈ $132.00 Million |
Skr33.61 Million ≈ $3.62 Million |
0.027x | -1.18% |
| 2021-12-31 | Skr1.17 Billion ≈ $126.05 Million |
Skr32.48 Million ≈ $3.50 Million |
0.028x | -40.73% |
| 2020-12-31 | Skr400.98 Million ≈ $43.15 Million |
Skr18.76 Million ≈ $2.02 Million |
0.047x | -64.82% |
| 2019-12-31 | Skr90.58 Million ≈ $9.75 Million |
Skr12.04 Million ≈ $1.30 Million |
0.133x | +13561.46% |
| 2018-12-31 | Skr91.43 Million ≈ $9.84 Million |
Skr89.00K ≈ $9.58K |
0.001x | +100.93% |
| 2017-12-31 | Skr61.27 Million ≈ $6.59 Million |
Skr-6.40 Million ≈ $-689.28K |
-0.105x | +85.59% |
| 2016-12-31 | Skr49.05 Million ≈ $5.28 Million |
Skr-35.59 Million ≈ $-3.83 Million |
-0.726x | -64.32% |
| 2015-12-31 | Skr71.47 Million ≈ $7.69 Million |
Skr-31.56 Million ≈ $-3.40 Million |
-0.442x | -250.18% |
| 2014-12-31 | Skr81.90 Million ≈ $8.81 Million |
Skr24.08 Million ≈ $2.59 Million |
0.294x | +32.26% |
| 2013-12-31 | Skr130.79 Million ≈ $14.08 Million |
Skr29.08 Million ≈ $3.13 Million |
0.222x | -20.92% |
| 2012-12-31 | Skr114.85 Million ≈ $12.36 Million |
Skr32.29 Million ≈ $3.47 Million |
0.281x | +44.66% |
| 2011-12-31 | Skr114.03 Million ≈ $12.27 Million |
Skr22.16 Million ≈ $2.39 Million |
0.194x | +187.88% |
| 2010-12-31 | Skr106.59 Million ≈ $11.47 Million |
Skr7.20 Million ≈ $774.38K |
0.068x | -22.98% |
| 2009-12-31 | Skr121.43 Million ≈ $13.07 Million |
Skr10.64 Million ≈ $1.15 Million |
0.088x | +208.41% |
| 2008-12-31 | Skr144.89 Million ≈ $15.59 Million |
Skr-11.71 Million ≈ $-1.26 Million |
-0.081x | +58.13% |
| 2007-12-31 | Skr120.21 Million ≈ $12.94 Million |
Skr-23.21 Million ≈ $-2.50 Million |
-0.193x | -277.51% |
| 2006-12-31 | Skr184.38 Million ≈ $19.84 Million |
Skr-9.43 Million ≈ $-1.01 Million |
-0.051x | +86.87% |
| 2005-12-31 | Skr70.28 Million ≈ $7.56 Million |
Skr-27.38 Million ≈ $-2.95 Million |
-0.390x | +30.18% |
| 2004-12-31 | Skr51.61 Million ≈ $5.55 Million |
Skr-28.80 Million ≈ $-3.10 Million |
-0.558x | +24.11% |
| 2003-12-31 | Skr42.14 Million ≈ $4.54 Million |
Skr-30.98 Million ≈ $-3.33 Million |
-0.735x | +49.68% |
| 2002-12-31 | Skr53.55 Million ≈ $5.76 Million |
Skr-78.24 Million ≈ $-8.42 Million |
-1.461x | -- |
About Carasent ASA
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient comm… Read more